Ipzz-137 Jun 2026

If the remaining engineering hurdles—chiefly cryogenic integration and error‑correction scaling—are resolved as projected, IPZZ‑137 will likely become the , ushering in an era where quantum advantage is not a theoretical curiosity but a daily engineering tool.

RNA‑seq of treated Burkitt lymphoma cells demonstrated rapid (<4 h) down‑regulation of >2,000 MYC‑responsive genes, including , LDHA , and NPM1 . Chromatin immunoprecipitation (ChIP‑seq) confirmed a dramatic loss of MYC occupancy at canonical E‑box promoters, while the global chromatin landscape remained largely intact—suggesting that IPZZ‑137 is not a broad transcriptional inhibitor but a highly specific PPI disruptor. ipzz-137